JP Jenkins Ltd | Finanzwire

BRIEF

published on 05/23/2024 at 09:37, 6 months ago

Lord David Prior Appointed as Chair of e-therapeutics' Board of Directors

Board Of Directors E-therapeutics RNAi Medicines Lord David Prior Healthcare Experience
PRESS RELEASE

published on 05/23/2024 at 09:32, 6 months ago

Lord David Prior Appointed as Chair of e-therapeutics’ Board of Directors
Lord David Prior appointed as Chair of e-therapeutics' Board of Directors. Bringing extensive healthcare and finance experience, he joins to drive AI drug discovery and advance GalOmic™ therapies for better patient treatments

E-therapeutics Lord David Prior Healthcare Experience Chair Appointment AI Drug Discovery
BRIEF

published on 05/17/2024 at 08:35, 6 months 6 days ago

Scirocco Energy Shares Begin Trading on JP Jenkins Platform

JP Jenkins Scirocco Energy Unlisted Shares European Energy Market Members Voluntary Liquidation
PRESS RELEASE

published on 05/17/2024 at 08:30, 6 months 6 days ago

Scirocco Energy plc shares now trading on JP Jenkins
Scirocco Energy plc's shares (SCIR) now available for trading on JP Jenkins share dealing platform, providing shareholders and investors access to liquidity and transparency

Liquidity JP Jenkins Share Trading Scirocco Energy Plc European Transition Energy Market
BRIEF

published on 05/09/2024 at 08:35, 6 months 14 days ago

E-therapeutics plc Shares Now Trading on JP Jenkins

JP Jenkins Share Trading E-therapeutics RNAi Medicines Computational Biology
PRESS RELEASE

published on 05/09/2024 at 08:30, 6 months 14 days ago

e-therapeutics plc shares now trading on JP Jenkins
e-therapeutics plc shares now trading on JP Jenkins. London-based company integrating computation and biological data for RNAi medicines joins JP Jenkins platform for unlisted assets trading

JP Jenkins RNAi Medicines E-therapeutics Plc Unlisted Assets Trading Computational Platform
BRIEF

published on 05/01/2024 at 08:08, 6 months 22 days ago

Redx Pharma Plc Shares Begin Trading on JP Jenkins Platform

JP Jenkins Share Trading Biotechnology Investments Redx Pharma Fibrotic Disease
PRESS RELEASE

published on 05/01/2024 at 08:03, 6 months 22 days ago

Redx Pharma Plc Shares now trading on JP Jenkins
Redx Pharma Plc's shares are now available for trading on JP Jenkins platform, providing shareholders with a secondary market option. JP Jenkins facilitates trading for unlisted assets

Secondary Market JP Jenkins Shares Trading Unlisted Assets Redx Pharma Plc
BRIEF

published on 04/29/2024 at 11:30, 6 months 24 days ago

Molecular Energies PLC Shares Begin Trading on JP Jenkins Platform

JP Jenkins Green Energy Sustainable Aviation Fuel Molecular Energies PLC Unlisted Shares Trading
PRESS RELEASE

published on 04/29/2024 at 11:25, 6 months 24 days ago

Molecular Energies PLC Shares now trading on JP Jenkins
Molecular Energies PLC shares are now available for trading on JP Jenkins, offering shareholders and investors a new opportunity for equity transactions

JP Jenkins Equity Transactions Share Trading Molecular Energies PLC Company Listing

Published on 11/22/2024 at 23:55, 1 day 4 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 4 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 5 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 5 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 5 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 10 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 10 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 10 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 11 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 12 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 1 day 13 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 21 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 8 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 10 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 10 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News